Relieving postoperative nephrectomy pain requires multimodal approaches. Peripheralblocks such as ESP block and M-TAPA block and multimodal analgesics reduce side effectsby reducing the use of other analgesics. This study aimed to compare the effectiveness oferector spinae plane block (ESP block) and modified thoracoabdominal nerve blocking withperichondrial approach (M-TAPA block) in postoperative analgesia management innephrectomy cases.
Relieving postoperative nephrectomy pain requires multimodal approaches. The most
commonly used in the treatment of pain are nonsteroidal anti-inflammatory drugs (NSAIDs),
opioids, and infiltration of local anesthetics. Due to the side effects of NSAIDs and
opioids, the application of regional analgesia techniques can reduce complications while
providing better analgesia quality. Peripheral blocks such as ESP block and M-TAPA block
and multimodal analgesics reduce side effects by reducing the use of other analgesics.
Pain is considered one of the most important factors affecting the quality of healing.
Postoperative pain delays the postanesthesia care unit, hospital stay, early ambulation,
increases resource utilization, and negatively affects patient satisfaction. If
postoperative analgesia is provided, all these negativities will be eliminated. This
study aimed to compare the effectiveness of erector spinae plane block (ESP block) and
modified thoracoabdominal nerve blocking with perichondrial approach (M-TAPA block) in
postoperative analgesia management in nephrectomy cases.
Other: NRS 0. hour
Numerical rating scala
Other: NRS 6. Hour
Numerical rating scala
Other: NRS 12. Hour
Numerical rating scala
Other: NRS 24. Hour
Numerical rating scala
Inclusion Criteria:
- All patients aged 18 and over with ASA1-2 who underwent elective nephrectomy
Exclusion Criteria:
- ASA ≥3
- Body mass index>35 kg/ m²
- Infection in the block area
- Coagulation disorder,
- Known allergy to local anesthetics
- Pregnant
- Patient with neuropathy
- Patient without cooperation
- Patient who refuses to participate in the study
- Patients under 18 years of age
BasaksehirCamSakuraH
Istanbul, Turkey
Hilal Akça
05548421509
drhllbs@gmail.com
Hilal Akça, Principal Investigator
BasaksehirCamSakuraH